COMMUNIQUÉS West-GlobeNewswire

Immuron to launch PROIBS® in the United States
04/09/2026
MELBOURNE, Australia, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to announce that it has executed an exclusive distribution agreement for PROIBS® in the United States with [...]
Supporting the continued long-term and stable ownership of Coloplast
04/09/2026
Coloplast has been informed that the Danish Financial Supervisory Authority (FSA) has today announced that it has notified Niels Peter Louis-Hansen that it has granted an exemption from the obligation to make a [...]
Raeliva Announces Rebrand and Expansion of Online Wellness Platform Beyond GLP-1 Care
04/09/2026
SAN DIEGO, CA, Sept. 04, 2026 (GLOBE NEWSWIRE) -- After building its initial patient base through online GLP-1 care under the OnlineSemaglutide.org brand, telehealth provider Raeliva is entering its next chapter with an [...]
Tangram Therapeutics annonce le passage aux cohortes de patients dans l’essai de phase 1/2 RESTORE-MASH évaluant le TGM-312 et la nomination du Dr Sonya Montgomery au poste de directrice du développement
04/09/2026
LONDRES, 04 sept. 2026 (GLOBE NEWSWIRE) -- Tangram Therapeutics ( « Tangram » ), société spécialisée dans le développement de médicaments innovants fondés sur l’ARNi visant à améliorer de manière significative la vie [...]
C4X Discovery to receive milestone payment for NRF2 exclusive worldwide license agreement
04/09/2026
4 September 2026 – C4X Discovery Holdings Ltd (“C4XD”), a pioneering Drug Discovery company, today announces that it will receive a $13 million milestone payment from AstraZeneca [LON: AZN], triggered by the entry of [...]
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
04/09/2026
COPENHAGEN, Denmark, September 4, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 285,900 as a consequence of employees’ exercise of warrants. [...]
102,000 Orion Corporation A shares converted into B shares
04/09/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 4 SEPTEMBER 2026 at 9.00 EEST 102,000 Orion Corporation A shares converted into B shares In accordance with [...]
Persica Pharmaceuticals publishes new analyses of antibiotic exposure-response, reinforcing the scientific case for PP353 in vertebrogenic Lumbar Back Pain
04/09/2026
The publication builds on Phase 1b PP353 data published in The Lancet's eClinicalMedicine, further supporting the rationale for a targeted, non-opioid approach to vertebrogenic Lumbar Back Pain Manuscript has been [...]
ONWARD Medical to Announce First-Half 2026 Results on September 9, 2026
04/09/2026
EINDHOVEN, the Netherlands, Sept. 04, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]
New Copenhagen facility to strengthen Europe's quantum manufacturing capabilities
04/09/2026
COPENHAGEN, Denmark, Sept. 04, 2026 (GLOBE NEWSWIRE) -- The state-of-the-art quantum facility will strengthen Europe’s ability to design, manufacture and scale next-generation quantum chips, helping to position the [...]
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
04/09/2026
–4-year data from the Phase 1/2a open-label extension (OLE) studies showed substantial and durable reductions in seizures and continuing improvements in cognition and behavior in patients treated with zorevunersen on [...]
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
03/09/2026
SEATTLE and VANCOUVER, British Columbia, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and [...]
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
03/09/2026
FREMONT, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- As clinical laboratories seek deeper cellular insights, greater efficiency, and more streamlined approaches to cell analysis, spectral flow cytometry leader Cytek [...]
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
03/09/2026
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to a new employee. Effective September 1, 2026, in [...]
DBV Technologies to Participate in Upcoming September Investor Conferences
03/09/2026
Châtillon, France, September 3, 2026 DBV Technologies to Participate in Upcoming September Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “ Company ”), a late [...]
DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre
03/09/2026
Châtillon, France, le 3 septembre (22 :30 CEST) 2026 DBV Technologies annonce sa participation à plusieurs conférences investisseurs en septembre DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock [...]
Monthly information on share capital and company voting rights
03/09/2026
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
03/09/2026
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 03 sept. 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
03/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]

Pages